DENVER — Patients with indications for implantable cardioverter defibrillators and wide QRS durations derived no additional benefit from left ventricular pacing compared with biventricular pacing, ...

Please provide your email address to receive an email when new articles are posted on . The novel extravascular implantable cardioverter defibrillator was implanted safely and was able to detect and ...

"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...

Although recent studies have proved that implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death (SCD) in patients with arrhythmogenic right ventricular dysplasia (ARVD), the ...

Washington, DC - Despite the vast improvement in mortality for those implanted with a device, the ICD population of the Multicenter Autonomic Defibrillator Implantation Trial II (MADIT II) had a ...

Right ventricular pacing restores an adequate heart rate in patients with atrioventricular block, but high percentages of right ventricular apical pacing may promote left ventricular systolic ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Aug. 25, 2004--St. Jude Medical, Inc. (NYSE:STJ) announced today U.S. Food and Drug Administration (FDA) approval and first implants of the Frontier(TM) II ...

Recurrent ventricular tachycardia among survivors of myocardial infarction with an implantable cardioverter–defibrillator (ICD) is frequent despite antiarrhythmic drug therapy. The most effective ...